181 related articles for article (PubMed ID: 20083500)
1. Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
Sato T; Shikama Y; Shimauchi H; Endo Y; Takada H
Innate Immun; 2011 Feb; 17(1):54-9. PubMed ID: 20083500
[TBL] [Abstract][Full Text] [Related]
2. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
3. Enhanced induction of a histamine-forming enzyme, histidine decarboxylase, in mice primed with NOD1 or NOD2 ligand in response to various Toll-like receptor agonists.
Funayama H; Huang L; Asada Y; Endo Y; Takada H
Innate Immun; 2010 Aug; 16(4):265-72. PubMed ID: 19710098
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Differences in Primary Murine Microglia Treated with NOD1, NOD2, and NOD1/2 Agonists.
Wasmuth S; Jalilvand TV; Laffer B; Busch M; Bauer D; Langmann T; Thanos S; Kasper M; Heiligenhaus A
J Mol Neurosci; 2020 Apr; 70(4):600-609. PubMed ID: 31907866
[TBL] [Abstract][Full Text] [Related]
6. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.
Wong CK; Hu S; Leung KM; Dong J; He L; Chu YJ; Chu IM; Qiu HN; Liu KY; Lam CW
Cell Mol Immunol; 2013 Jul; 10(4):317-29. PubMed ID: 23524653
[TBL] [Abstract][Full Text] [Related]
7. NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.
Jeon DI; Park SR; Ahn MY; Ahn SG; Park JH; Yoon JH
Int J Mol Med; 2012 Apr; 29(4):699-703. PubMed ID: 22218461
[TBL] [Abstract][Full Text] [Related]
8. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
9. The role of Nod1 signaling in corneal neovascularization.
Kim SJ; Lee JW; Yeo ED; Yu SL; Jean WS; Kim JH; Park CG; Lee HY; Han SY; Park JH; Ko BY; Kang J
Cornea; 2013 May; 32(5):674-9. PubMed ID: 23328697
[TBL] [Abstract][Full Text] [Related]
10. The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.
Dagil YA; Arbatsky NP; Alkhazova BI; L'vov VL; Mazurov DV; Pashenkov MV
PLoS One; 2016; 11(8):e0160784. PubMed ID: 27513337
[TBL] [Abstract][Full Text] [Related]
11. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
Kvarnhammar AM; Petterson T; Cardell LO
Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
[TBL] [Abstract][Full Text] [Related]
12. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.
Farzi A; Reichmann F; Meinitzer A; Mayerhofer R; Jain P; Hassan AM; Fröhlich EE; Wagner K; Painsipp E; Rinner B; Holzer P
Brain Behav Immun; 2015 Feb; 44():106-20. PubMed ID: 25218901
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling.
Takada H; Uehara A
Curr Pharm Des; 2006; 12(32):4163-72. PubMed ID: 17100619
[TBL] [Abstract][Full Text] [Related]
15. Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1.
Uehara A; Fujimoto Y; Kawasaki A; Kusumoto S; Fukase K; Takada H
J Immunol; 2006 Aug; 177(3):1796-804. PubMed ID: 16849490
[TBL] [Abstract][Full Text] [Related]
16. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo.
Cartwright N; Murch O; McMaster SK; Paul-Clark MJ; van Heel DA; Ryffel B; Quesniaux VF; Evans TW; Thiemermann C; Mitchell JA
Am J Respir Crit Care Med; 2007 Mar; 175(6):595-603. PubMed ID: 17234906
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
[TBL] [Abstract][Full Text] [Related]
18. Intracellular adhesion molecule-1 is regulated by porphyromonas gingivalis through nucleotide binding oligomerization domain-containing proteins 1 and 2 molecules in periodontal fibroblasts.
Liu J; Duan J; Wang Y; Ouyang X
J Periodontol; 2014 Feb; 85(2):358-68. PubMed ID: 23688098
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1).
Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M
Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936
[TBL] [Abstract][Full Text] [Related]
20. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.
Werts C; le Bourhis L; Liu J; Magalhaes JG; Carneiro LA; Fritz JH; Stockinger S; Balloy V; Chignard M; Decker T; Philpott DJ; Ma X; Girardin SE
Eur J Immunol; 2007 Sep; 37(9):2499-508. PubMed ID: 17705131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
